Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology

References

• Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006; 20: 207–25
   PubMed Web of Science ®Google Scholar
• Ozols RF, Rubin SC, Thomas GM, Robboy SJ. Epithelial ovarian cancer. Principles and practice of gynaecologic oncology, WJ Hoskins, CA Perez, RC Young. Lippincott Williams and Wilkins, Philadelphia, PA 2000; 981–1058
   Google Scholar
• Benedet JL, Percorelli S. Staging classifications and clinical practice guidelines of gynaecologic cancers. The International Federation of Gynecology and Obstetrics (FIGO). Int J Gyn Obst. 2000; 70: 207–312
   PubMed Web of Science ®Google Scholar
• Hortin GL, Sviridov D. Diagnostic potential for urinary proteomics. Pharmacogenomics. 2007; 8: 237–55
   PubMed Web of Science ®Google Scholar
• Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M. The human urinary proteome contains more than 1500 proteins including a large proportion of membranes proteins. GenomeBiology. 2006; 7: R80
   Google Scholar
• Kumar S, Tsai CJ, Nussinov R. Temperature range of thermodynamic stability for the native state of reversible two-state proteins. Biochemistry. 2003; 42: 4864–73
   PubMed Web of Science ®Google Scholar
• Marshall T, Williams K. Two-dimensional electrophoresis of human urinary proteins following concentration by dye precipitation. Electrophoresis. 1996; 17: 1265–72
   PubMed Web of Science ®Google Scholar
• Pieper R, Gatlin CL, McGrath AM, Makusky AJ, Mondal M, Seonarain M, et al. Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics. 2004; 4: 1159–74
   PubMed Web of Science ®Google Scholar
• Thongboonkerd V, Chutipongtanate S, Kanlaya R. Systematic evaluation of sample preparation methods for gel-based urinary proteomics: quantity, quality, and variability. J Proteome Res 2006; 5: 183–91
   PubMed Web of Science ®Google Scholar
• Thongbookerd V. Proteomic analysis of renal diseases: unravelling the pathophysiology and biomarker discovery. Expert Rev Proteomics. 2005; 2: 349–66
   PubMed Web of Science ®Google Scholar
• Papale M, Pedicillo MC, Thatcher BJ, Di Paolo S, Lo Muzio L, Bufo P, et al. Urine profiling by SELDI-TOF/MS: monitoring of the critical steps in sample collection, handling and analysis. J Chromatogr. 2007; 856: 205–13
   Web of Science ®Google Scholar
• Oh J, Pyo JH, Jo EH, Hwang SI, Kang SC, Jung JH, et al. Establishment of a near-standard two-dimensional human urine proteomic map. Proteomics. 2004; 4: 3485–97
   PubMed Web of Science ®Google Scholar
• Castagna A, Cecconi D, Sennels L, Rappsilber J, Guerrier L, Fortis F, et al. Exploring the hidden human urinary proteome via ligand library beads. J Proteome Res. 2005; 4: 1917–30
   PubMed Web of Science ®Google Scholar
• Thulasiraman V, Lin S, Gheorghiu L, Lathrop J, Lomas L, Hammond D, et al. Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands. Electrophoresis. 2005; 26: 3561–71
   PubMed Web of Science ®Google Scholar
• Righetti PG, Boschetti E, Lomas L, Citterio A. Protein equalizer technology: the quest for a ‘democratic proteome’. Proteomics. 2006; 6: 3980–92
   PubMed Web of Science ®Google Scholar
• Woong-Shick A, Sung-Pil P, Su-Mi B, Joon-Mo L, Sung-Eun N, Gye-Hyun N, et al. Identification of hemoglobin-alpha and -beta subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer. Cancer Sci. 2005; 96: 197–201
   PubMed Web of Science ®Google Scholar
• Zhang Z, Bast RC, Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, et al. Three biomarkers identified from serum pro-teomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004; 64: 5882–90
   PubMed Web of Science ®Google Scholar
• Kozak KR, Su F, Whitelegge JP, Faull K, Reddy S, Farias-Eisner R. Characterization of serum biomarker for detection of early stage ovarian cancer. Proteomics. 2005; 5: 4589–96
   PubMed Web of Science ®Google Scholar
• Ye B, Skates S, Mok SC, Horick NK, Rosenberg HF, Vitonis A, et al. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clin Cancer Res. 2006; 12: 432–41
   PubMed Web of Science ®Google Scholar
• Mor G, Visintin I, Lai Y, Zhao H, Schwarts P, Rutherford T, et al. Serum protein markers for early detection of ovarian cancer. PNAS. 2005; 102: 7677–82
   PubMed Web of Science ®Google Scholar
• Gortzak-Uzan L, Ignatchenko A, Evangelou AI, Agochiya M, Brown KA, St Onge P, et al. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatics analyses to identify putative biomarkers. J Proteome Res. 2008; 7: 339–51
   PubMed Web of Science ®Google Scholar
• Menon U. Ovarian cancer screening. Oncology. 2004; 171: 323–4
   Google Scholar
• Jacobs IJ, Skates SJ, MacDonald N, Menon U, Rosenthal AN, Davies AP, et al. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet. 1999; 353: 1207–10
   PubMed Web of Science ®Google Scholar
• Jacobs IJ, Menon U. Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics. 2004; 3: 355–66
   PubMed Web of Science ®Google Scholar
• Moore RG, Brown AK, Miller MC, Skates S, Allard WJ, Verch T, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol. 2008; 108: 402–8
   PubMed Web of Science ®Google Scholar
• Visintin I, Feng Z, Longton G, Ward DC, Alvero AB, Lai Y, et al. Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res. 2008; 14: 1065–72
   PubMed Web of Science ®Google Scholar
• Sahni A, Simpson-Haidaris PJ, Sahni SK, Vaday GG, Francis CW. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost. 2008; 6: 176–83
   PubMed Web of Science ®Google Scholar
• Twardowski T, Fertala A, Orgel JP, San Antonio JD. Type I collagen and collagen mimetics as angiogenesis promoting superpolymers. Curr Pharm Des. 2007; 13: 3608–21
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420: 860–7
   PubMed Web of Science ®Google Scholar
• A Giede KC, Kieser K, Dodge J, Rosen B. Who should operate on patients with ovarian cancer?. Gynecol Oncol. 2005; 99: 447–61
   PubMed Web of Science ®Google Scholar